A peptide-duocarmycin conjugate targeting the Thomsen-Friedenreich antigen has potent and selective antitumour activity

Cartwright, Oliver Charles, Beekman, Andrew Michael, Cominetti, Marco M D, Russell, David A and Searcey, Mark (2020) A peptide-duocarmycin conjugate targeting the Thomsen-Friedenreich antigen has potent and selective antitumour activity. Bioconjugate Chemistry, 31 (7). 1745–1749. ISSN 1043-1802

[img] PDF (Accepted_Manuscript) - Submitted Version
Restricted to Repository staff only until 9 June 2021.

Download (307kB) | Request a copy

Abstract

Solid phase synthesis allowed the rapid generation of a peptide-drug conjugate. A peptide targeting the Thomsen-Friedenreich antigen (TFα) was conjugated to the alkylating subunit of the potent cytotoxin duocarmycin SA. The compound, containing a cathepsin B cleavable linker, was shown to be active and selective against TFα expressing tumour cell lines.

Item Type: Article
Faculty \ School: Faculty of Science > School of Pharmacy
Faculty of Science > School of Chemistry
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 17 Jun 2020 00:12
Last Modified: 28 Jul 2020 00:13
URI: https://ueaeprints.uea.ac.uk/id/eprint/75612
DOI: 10.1021/acs.bioconjchem.0c00282

Actions (login required)

View Item View Item